Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide observational study in non-disabling ischemic cerebrovascular disease
ChiCTR-OPC-16008069Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butylphthalide in Ischaemic cerebral disease, ischemic stroke and transient ischaemic attack (TIA) (2 cohorts), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Incidence of stroke. Planned start Apr 2016; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
Ischaemic cerebral diseaseischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on ChiCTR-OPC-16008069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008069.